Quoin Pharmaceuticals, Ltd. (QNRX)
Largest Insider Buys in Sector
QNRX Stock Price History Chart
QNRX Stock Performance
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Insider Activity of Quoin Pharmaceuticals, Ltd.
Over the last 12 months, insiders at Quoin Pharmaceuticals, Ltd. have bought $80,858 and sold $217 worth of Quoin Pharmaceuticals, Ltd. stock.
On average, over the past 5 years, insiders at Quoin Pharmaceuticals, Ltd. have bought $80,858 and sold $217 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Myers Michael (Chief Executive Officer) — $28,916. Carter Denise P. (Chief Operating Officer) — $28,737. Dunn Gordon (Chief Financial Officer) — $23,205.
The last purchase of 20,000 shares for transaction amount of $16,200 was made by Dunn Gordon (Chief Financial Officer) on 2024‑09‑10.
List of Insider Buy and Sell Transactions, Quoin Pharmaceuticals, Ltd.
| 2024-09-10 | Chief Financial Officer | 20,000 0.5852% | $0.81 | $16,200 | -24.74% | |||
| 2024-09-09 | Chief Financial Officer | 8,856 0.1833% | $0.79 | $7,005 | -44.48% | |||
| 2024-09-04 | Chief Executive Officer | 37,094 0.8928% | $0.77 | $28,421 | -28.96% | |||
| 2024-09-04 | Chief Operating Officer | 31,813 0.7825% | $0.78 | $24,912 | -28.96% | |||
| 2024-09-03 | Chief Operating Officer | 5,922 0.1416% | $0.65 | $3,825 | -15.28% | |||
| 2024-09-03 | Chief Executive Officer | 800 0.0183% | $0.62 | $495 | -15.28% | |||
| 2024-06-07 | Sale | director | 297 0.008% | $0.73 | $217 | -15.99% |